TipRanks
InSilico Medicine Cayman TopCo (HK:3696)
:3696
Hong Kong Market
3696
InSilico Medicine Cayman TopCo
RESEARCH TOOLSreports

InSilico Medicine Cayman TopCo (3696) Stock Forecast & Price Target

17 Followers
See the Price Targets and Ratings of:

3696 Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
InSilico
Medicine Cayman TopCo
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3696 Stock 12 Month Forecast

Average Price Target

HK$79.11
▲(77.52% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for InSilico Medicine Cayman TopCo in the last 3 months. The average price target is HK$79.11 with a high forecast of HK$86.50 and a low forecast of HK$71.00. The average price target represents a 77.52% change from the last price of HK$44.56.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"HK$28","87":"HK$87","42.75":"HK$42.8","57.5":"HK$57.5","72.25":"HK$72.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":86.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$86.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":79.105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$79.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$71.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,42.75,57.5,72.25,87],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.1,62.13076923076923,64.16153846153847,66.1923076923077,68.22307692307692,70.25384615384615,72.28461538461539,74.31538461538462,76.34615384615384,78.37692307692308,80.40769230769232,82.43846153846154,84.46923076923076,{"y":86.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.1,61.56192307692308,63.02384615384616,64.48576923076924,65.94769230769231,67.40961538461539,68.87153846153846,70.33346153846153,71.79538461538462,73.25730769230769,74.71923076923078,76.18115384615385,77.64307692307693,{"y":79.105,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.1,60.93846153846154,61.776923076923076,62.61538461538461,63.45384615384616,64.29230769230769,65.13076923076923,65.96923076923078,66.8076923076923,67.64615384615385,68.48461538461538,69.32307692307693,70.16153846153847,{"y":71,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.98,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":29.98,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":29.98,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":37.14,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":60.25,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":58.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.05,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.58,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.62,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.1,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$86.50Average Price TargetHK$79.11Lowest Price TargetHK$71.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
KeyBanc Analyst forecast on HK:3696
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
HK$86.5
Buy
94.12%
Upside
Reiterated
09/17/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
Citi Analyst forecast on HK:3696
Unknown Analyst
Citi
Not Ranked
Citi
HK$85
Buy
90.75%
Upside
Initiated
09/03/26
InSilico Medicine Cayman TopCo (3696) Initiated with a Buy at Citi
J.P. Morgan Analyst forecast on HK:3696
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
HK$71
Buy
59.34%
Upside
Reiterated
09/01/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
UBS Analyst forecast on HK:3696
Unknown Analyst
UBS
Not Ranked
UBS
HK$77
Buy
72.80%
Upside
Reiterated
08/27/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
Guosheng Securities Analyst forecast on HK:3696
Unknown Analyst
Guosheng Securities
Not Ranked
Guosheng Securities
HK$81.9
Buy
83.80%
Upside
Reiterated
08/14/26
Analysts' Top Technology Picks: InSilico Medicine Cayman TopCo (HK:3696), Semiconductor Manufacturing International (HK:0981)
Guotai Haitong Analyst forecast on HK:3696
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$73.23
Buy
64.34%
Upside
Reiterated
08/10/26
Guotai Haitong Reaffirms Their Buy Rating on InSilico Medicine Cayman TopCo (3696)
HSBC Analyst forecast on HK:3696
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$84.5
Buy
89.63%
Upside
Reiterated
07/22/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
CICC Analyst forecast on HK:3696
Unknown Analyst
CICC
Not Ranked
CICC
HK$76.8
Buy
72.35%
Upside
Reiterated
04/07/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
GF Securities Analyst forecast on HK:3696
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$77.97
Buy
74.98%
Upside
Reiterated
03/26/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
KeyBanc Analyst forecast on HK:3696
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
HK$86.5
Buy
94.12%
Upside
Reiterated
09/17/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
Citi Analyst forecast on HK:3696
Unknown Analyst
Citi
Not Ranked
Citi
HK$85
Buy
90.75%
Upside
Initiated
09/03/26
InSilico Medicine Cayman TopCo (3696) Initiated with a Buy at Citi
J.P. Morgan Analyst forecast on HK:3696
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
HK$71
Buy
59.34%
Upside
Reiterated
09/01/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
UBS Analyst forecast on HK:3696
Unknown Analyst
UBS
Not Ranked
UBS
HK$77
Buy
72.80%
Upside
Reiterated
08/27/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
Guosheng Securities Analyst forecast on HK:3696
Unknown Analyst
Guosheng Securities
Not Ranked
Guosheng Securities
HK$81.9
Buy
83.80%
Upside
Reiterated
08/14/26
Analysts' Top Technology Picks: InSilico Medicine Cayman TopCo (HK:3696), Semiconductor Manufacturing International (HK:0981)
Guotai Haitong Analyst forecast on HK:3696
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$73.23
Buy
64.34%
Upside
Reiterated
08/10/26
Guotai Haitong Reaffirms Their Buy Rating on InSilico Medicine Cayman TopCo (3696)
HSBC Analyst forecast on HK:3696
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$84.5
Buy
89.63%
Upside
Reiterated
07/22/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
CICC Analyst forecast on HK:3696
Unknown Analyst
CICC
Not Ranked
CICC
HK$76.8
Buy
72.35%
Upside
Reiterated
04/07/26
New Buy Rating for InSilico Medicine Cayman TopCo (3696), the Technology Giant
GF Securities Analyst forecast on HK:3696
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$77.97
Buy
74.98%
Upside
Reiterated
03/26/26
InSilico Medicine Cayman TopCo (3696): New Buy Recommendation for This Technology Giant
Stocks with the Highest Top Analyst Consensus in the Technology Sector
UCTTUltra Clean Holdings
SIMOSilicon Motion
ANETArista Networks
CLBTCellebrite DI
CLSCelestica
Find stocks in the Technology sector that are highly recommended by Top Performing Analysts.

3696 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
4
7
9
9
6
Buy
1
1
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
8
10
10
6
In the current month, 3696 has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 3696 average Analyst price target in the past 3 months is 79.11.
Each month's total comprises the sum of three months' worth of ratings.

3696 Financial Forecast

3696 Earnings Forecast

The previous quarter’s earnings for 3696 were HK$0.47.
The previous quarter’s earnings for 3696 were HK$0.47.

3696 Sales Forecast

The previous quarter’s earnings for 3696 were HK$831.75M.
The previous quarter’s earnings for 3696 were HK$831.75M.

3696 Stock Forecast FAQ

What is HK:3696’s average 12-month price target, according to analysts?
Based on analyst ratings, InSilico Medicine Cayman TopCo’s 12-month average price target is 79.11.
    What is HK:3696’s upside potential, based on the analysts’ average price target?
    InSilico Medicine Cayman TopCo has 77.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is InSilico Medicine Cayman TopCo a Buy, Sell or Hold?
          InSilico Medicine Cayman TopCo has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is InSilico Medicine Cayman TopCo’s share price target?
            The average share price target for InSilico Medicine Cayman TopCo is 79.11. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$86.50 ,and the lowest forecast is HK$71.00. The average share price target represents 77.52% Increase from the current price of HK$44.56.
              What do analysts say about InSilico Medicine Cayman TopCo?
              InSilico Medicine Cayman TopCo’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of InSilico Medicine Cayman TopCo?
                To buy shares of HK:3696, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.